Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

First-in-Human Experience Using a Novel Shape-Adaptive Pulsed Field Ablation Catheter in Persistent Atrial Fibrillation

NCT07301190 is registered in ClinicalTrials.gov with The Third People's Hospital of Chengdu as lead sponsor.

NCT NCT07301190
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07301190 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
First-in-Human Experience Using a Novel Shape-Adaptive Pulsed Field Ablation Catheter in Persistent Atrial Fibrillation
Lead sponsor
The Third People's Hospital of Chengdu
Phase
Not applicable
Overall status
Recruiting
Start date
June 11, 2025
Completion date
April 15, 2027
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

persistent atrial fibrillation